your symptoms may get better before the infection is completely treated. 7 µg/ml and 0. levofloxacin is used to treat infections of the sinuses, skin, lungs, ears, airways, bones, and joints caused by susceptible bacteria. levofloxacin pharmacokinetics are linear and predictable after single and multiple oral dosing regimens. these recommendations apply to patients with normal renal function (i. v levaquin man. do not use this medication without telling your doctor if you are breast-feeding a baby 500mg levaquin. coli, campylobacter jejuni, and shigella bacteria drug interaction levaquin more. continue to take levofloxacin even if you feel well. the blister fluid to plasma auc ratio is approximately 1 500 levaquin tablet. gender: there are no significant differences in levofloxacin pharmacokinetics between male and female subjects when the differences in creatinine clearance are taken into consideration. renal insufficiency: clearance of levofloxacin is reduced and plasma elimination half-life is prolonged in patients with impaired renal function (creatinine clearance ?80 ml/min), and dosage adjustment may be required in such patients to avoid accumulation dental levaquin prophylaxis. adult dosage levaquin can pass into breast milk and may harm a nursing baby levaquin birth control. levofloxacin is in a class of antibiotics called fluoroquinolones levaquin injection. it works by eliminating bacteria that cause infections dose levaquin. there have been reports of changes in blood sugar in patients treated with other fluoroquinolones and antidiabetic agents. to reduce the development of drug-resistant bacteria and maintain the effectiveness of adult dosage levaquin® (levofloxacin) and other antibacterial drugs, adult dosage levaquin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. tendon ruptures that required surgical repair or resulted in prolonged disability have been reported in patients receiving quinolones, including levofloxacin, during and after therapy levaquin and tiredness. the peak and trough plasma concentrations attained following multiple once-daily oral 500 mg regimens were approximately 5. excretion: the major route of elimination of levofloxacin in humans is as unchanged drug in urine 500mg levaquin levofloxacin tablet. hepatic insufficiency: pharmacokinetics studies in hepatically impaired patients have not been conducted levaquin dosing. levofloxacin binding to serum proteins is independent of the drug concentration. the plasma concentration profile of levofloxacin after i. levofloxacin dose adjustment based on age alone is not necessary. oral doses should be administered at least two hours before or two hours after antacids containing magnesium, aluminum, as well as sucralfate, metal cations such as iron, and multivitamin preparations with zinc or videx® (didanosine), chewable/ buffered tablets or the pediatric powder for oral solution. the absolute bioavailability of a 500 mg oral dose of levofloxacin is approximately 99% levaquin prescribed for. take adult dosage levaquin on an empty stomach 1 hour before or 2 hours after meals levaquin 750 mg. drug absorption appears to be unaffected by age 750 levaquin mg. oral administration with food slightly prolongs the time to peak concentration by approximately 1 hour and slightly decreases the peak concentration by approximately 14%. v. the drug should be discontinued at the first appearance of a skin rash or any other sign of hypersensitivity. for patients with altered renal function see the patients with impaired renal function subsection. drink several extra glasses of fluid each day to prevent crystals from forming in the urine. this risk is increased in patients over 65 years old, and is further increased with concomitant corticosteroid therapy allergy levaquin.